- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Estrogen Receptor Antagonists
Total 37488 results
-
Eli Lilly and CompanyActive, not recruitingBreast NeoplasmsUnited States, Spain, Germany, Taiwan, Japan, Canada, Australia, Belgium, Denmark, France, Finland, Mexico, Italy, Korea, Republic of, Poland, Russian Federation, Switzerland, Puerto Rico, Romania, Greece
-
Novartis PharmaceuticalsActive, not recruiting
-
PfizerWithdrawnBreast Cancer | Ovarian Cancer | Non-small Cell Lung Cancer (NSCLC) | Solid Tumors | Liposarcoma | Endometrial
-
Massachusetts General HospitalExelixisActive, not recruitingBreast CancerUnited States
-
UNICANCERTerminated
-
Genentech, Inc.TerminatedBreast CancerUnited States, Spain, United Kingdom, Germany, Korea, Republic of, Australia
-
Loyola UniversityCompletedOveractive BladderUnited States
-
M.D. Anderson Cancer CenterNot yet recruitingHormone Receptor-positive Human Epidermal Growth Factor 2-negative | Metastatic Invasive LObular CarcinomaUnited States
-
Institut Paoli-CalmettesMerck KGaA, Darmstadt, Germany; National Cancer Institute, FranceNot yet recruiting
-
Tianjin Medical University Cancer Institute and...Not yet recruiting
-
Kashiv BioSciences, LLCCompletedMetastatic Breast CancerJordan
-
Betta Pharmaceuticals Co., Ltd.Active, not recruiting
-
Nuvation Bio Inc.WithdrawnBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | Breast Carcinoma | Cancer of Breast | Malignant Tumor of Breast | Breast Tumor | Cancer of the BreastUnited States
-
University of Colorado, DenverUnited States Department of DefenseActive, not recruitingBreast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterDebiopharm International SACompletedBreast CancerUnited States
-
Roswell Park Cancer InstituteTerminated
-
Stanford UniversityAstraZenecaCompletedProstatic Neoplasms | Prostate CancerUnited States
-
AstraZenecaCompleted
-
The Center for Rheumatic Disease, Allergy, & ImmunologyAstraZenecaCompletedSystemic Lupus ErythematosusUnited States
-
AstraZenecaCompletedBreast CancerUnited States, Brazil, United Kingdom, Germany, Austria, India
-
National Institute on Aging (NIA)Completed
-
National Institute of Neurological Disorders and...Completed
-
National Institute of Neurological Disorders and...Jefferson Medical College of Thomas Jefferson UniversityCompletedTurner's SyndromeUnited States
-
Mayo ClinicCompletedOsteoporosis | PostmenopausalUnited States
-
Canadian Cancer Trials GroupPfizerCompleted
-
Royal Marsden NHS Foundation TrustPfizer; AstraZeneca; Institute of Cancer Research, United Kingdom; UNICANCER; Gustave... and other collaboratorsRecruitingHER2-negative Breast Cancer | ER+ Breast CancerUnited Kingdom, France
-
National Center for Research Resources (NCRR)Unknown
-
Novartis PharmaceuticalsRecruitingBreast CancerGermany, Italy, Belgium, Denmark, France, Spain, Finland, Hungary, Ireland, Czechia, Greece, Canada, Portugal, Slovakia, Bulgaria, Poland, Romania
-
Novartis PharmaceuticalsCompletedAdvanced Breast CancerBelgium, Italy, Czechia, Hungary, Canada, Netherlands, Germany, Singapore, Australia, Denmark, Poland, Switzerland, Korea, Republic of, Spain, Thailand, Lebanon, Austria, Bulgaria, Russian Federation, Norway, Jordan, United States, ... and more
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityUnknownMetastatic Breast CancerChina
-
Novartis PharmaceuticalsCompletedBreast CancerFrance, Singapore, Italy, Korea, Republic of, Taiwan, United Kingdom, Spain, United States
-
Swiss Group for Clinical Cancer ResearchCompletedBreast CancerSwitzerland, Belgium
-
Biyun Wang, MDRecruiting
-
The Methodist Hospital Research InstituteEli Lilly and CompanyRecruitingHER2-negative Breast Cancer | ER-Positive Breast CancerUnited States
-
Novartis PharmaceuticalsCompletedBreast CancerUnited States, France, Spain, United Kingdom, Austria, Germany, Taiwan, Australia, Italy, Israel, Russian Federation, Korea, Republic of, Hong Kong, Thailand, Canada, Hungary, Japan, Lebanon, Belgium, Bulgaria, Greece, Argentina, Peru, Czech... and more
-
Novartis PharmaceuticalsCompletedBreast CancerUnited States, China, Belgium, Canada, France, Italy, Taiwan, United Kingdom, Hungary, Australia, Spain, Germany, Singapore, Austria, Japan, Israel, Russian Federation, Korea, Republic of, Thailand, Slovakia, South Africa, Switzer... and more
-
AstraZenecaCompletedAdvanced Breast Cancer | Metastatic Breast CancerJapan
-
Kafrelsheikh UniversityNot yet recruiting
-
State University of New York at BuffaloAmerican Diabetes AssociationTerminatedType 2 Diabetes | Hypogonadotropic HypogonadismUnited States
-
Repros Therapeutics Inc.CompletedDrug-drug InteractionUnited States
-
Repros Therapeutics Inc.CompletedType 2 Diabetes Mellitus | Secondary HypogonadismUnited States
-
PfizerCompletedOsteoporosisUnited States, Norway, Brazil, Netherlands
-
Ain Shams Maternity HospitalUnknown
-
Centre Hospitalier Universitaire VaudoisUnknown
-
University of Auckland, New ZealandAuckland Medical Research Foundation; Mercia Barnes Trust of the Royal Australian...CompletedPolycystic Ovary SyndromeNew Zealand
-
The First Affiliated Hospital with Nanjing Medical...Not yet recruitingHormone Receptor-positive Advanced Breast Cancer
-
Fudan UniversityNot yet recruitingHormone Receptor-positive Advanced Breast Cancer
-
Massachusetts General HospitalPuma Biotechnology, Inc.; Celcuity, Inc.WithdrawnMetastatic Breast Cancer | Invasive Breast Cancer | HER2-negative Breast Cancer | ER Positive Breast Cancer | PR-Positive Breast Cancer | Stage IV (Metastatic) Breast CancerUnited States
-
Eli Lilly and CompanyCompletedBreast CancerNetherlands, Spain, Italy, France, Germany